Alphabet Inc’s Barinthus Biotherapeutics BRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Hold |
1,513,644
| – | – | 0.07% | 28 |
|
|
2025
Q1 | $1.47M | Hold |
1,513,644
| – | – | 0.09% | 27 |
|
|
2024
Q4 | $1.83M | Hold |
1,513,644
| – | – | 0.11% | 23 |
|
|
2024
Q3 | $1.8M | Hold |
1,513,644
| – | – | 0.1% | 26 |
|
|
2024
Q2 | $2.12M | Hold |
1,513,644
| – | – | 0.11% | 29 |
|
|
2024
Q1 | $3.6M | Hold |
1,513,644
| – | – | 0.14% | 28 |
|
|
2023
Q4 | $5.59M | Hold |
1,513,644
| – | – | 0.26% | 24 |
|
|
2023
Q3 | $4.68M | Hold |
1,513,644
| – | – | 0.3% | 23 |
|
|
2023
Q2 | $3.12M | Hold |
1,513,644
| – | – | 0.17% | 28 |
|
|
2023
Q1 | $3.39M | Hold |
1,513,644
| – | – | 0.19% | 27 |
|
|
2022
Q4 | $3.56M | Hold |
1,513,644
| – | – | 0.21% | 28 |
|
|
2022
Q3 | $4.84M | Hold |
1,513,644
| – | – | 0.25% | 30 |
|
|
2022
Q2 | $6.74M | Hold |
1,513,644
| – | – | 0.37% | 30 |
|
|
2022
Q1 | $7.87M | Sell |
1,513,644
-190,700
| -11% | -$992K | 0.26% | 33 |
|
|
2021
Q4 | $18.9M | Sell |
1,704,344
-100
| -0% | -$1.11K | 0.46% | 28 |
|
|
2021
Q3 | $26.8M | Hold |
1,704,444
| – | – | 0.64% | 18 |
|
|
2021
Q2 | $28.6M | Buy |
+1,704,444
| New | +$28.6M | 0.58% | 18 |
|